John C. Thomas - 23 Jun 2022 Form 4 Insider Report for Virios Therapeutics, Inc. (DWTX)

Role
Director
Signature
/s/ Greg Duncan, Attorney-in-Fact
Issuer symbol
DWTX
Transactions as of
23 Jun 2022
Net transactions value
$0
Form type
4
Filing time
30 Jun 2022, 14:01:46 UTC
Previous filing
04 Jan 2022
Next filing
20 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRI Stock Option (right to buy) Award $0 +5,250 $0.000000 5,250 23 Jun 2022 Common Stock 5,250 $4.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest 100% on June 23, 2023, one year following the grant date.